Literature DB >> 15659002

Prevalence of over-the-counter drug-related overdoses at Accident and Emergency departments in Northern Ireland--a retrospective evaluation.

M Wazaify1, S Kennedy, C M Hughes, J C McElnay.   

Abstract

BACKGROUND AND OBJECTIVES: One major concern associated with misuse/abuse of over-the-counter (OTC) products is the potential for over-dosage. The aim of this research study was to evaluate, over a 3-month period, OTC medicine-related overdoses (those involving OTC drugs only and OTC drugs in combination with other drugs) that led to patients presenting at the Accident and Emergency (A & E) departments in four Belfast hospitals.
METHODS: A data collection sheet was designed to capture the information required from the A & E records in each hospital. A retrospective week-by-week data collection, reviewing A & E records, took place over a 3-month period (starting on 1 December 2002). All data related to cases presenting at the A & E departments because of drug overdoses (either accidental or deliberate according to Read Clinical Classification) were included in the study. Data were coded and entered into a custom designed SPSS database for analysis, using Chi square and Fisher exact tests.
RESULTS: OTC drug-related overdoses comprised 40.1% of all overdoses, of which 24.0% were OTC-only overdoses. Those who overdosed on OTC drugs (solely or combined with other drugs) were mainly female (62.3%) and in the age category 31-50 years (44.9%; P <0.05). The majority (n=215) of OTC-related overdoses were intentional, whereas only 28 were accidental. Of those who attended the A &amp; E departments and had an overdose history, one-third overdosed on OTC-related products and two-thirds overdosed on OTC drugs only.
CONCLUSIONS: OTC drugs accounted for a significant proportion of overdose presentations at the A &amp; E departments in Northern Ireland. Higher awareness of the potential of OTC product use in overdose cases (intentional or accidental) is recommended for both the public and health care professionals.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15659002     DOI: 10.1111/j.1365-2710.2004.00607.x

Source DB:  PubMed          Journal:  J Clin Pharm Ther        ISSN: 0269-4727            Impact factor:   2.512


  7 in total

1.  Use of over-the-counter (OTC) drugs and perceptions of OTC drug safety among German adults.

Authors:  E Barrenberg; E Garbe
Journal:  Eur J Clin Pharmacol       Date:  2015-08-25       Impact factor: 2.953

2.  Over-the-counter medications containing diphenhydramine and doxylamine used by older adults to improve sleep.

Authors:  Olufunmilola Abraham; Loren Schleiden; Steven M Albert
Journal:  Int J Clin Pharm       Date:  2017-05-02

3.  Consumer views on safety of over-the-counter drugs, preferred retailers and information sources in Sweden: after re-regulation of the pharmacy market.

Authors:  Tommy Westerlund; Sahra Barzi; Cecilia Bernsten
Journal:  Pharm Pract (Granada)       Date:  2017-03-15

Review 4.  Natural Dietary Pigments: Potential Mediators against Hepatic Damage Induced by Over-The-Counter Non-Steroidal Anti-Inflammatory and Analgesic Drugs.

Authors:  Herson Antonio González-Ponce; Ana Rosa Rincón-Sánchez; Fernando Jaramillo-Juárez; Han Moshage
Journal:  Nutrients       Date:  2018-01-24       Impact factor: 5.717

5.  OTC analgesics and drug interactions: clinical implications.

Authors:  A Mark Fendrick; Deborah E Pan; Grace E Johnson
Journal:  Osteopath Med Prim Care       Date:  2008-02-07

6.  Characteristics of hospital-treated intentional drug overdose in Ireland and Northern Ireland.

Authors:  Eve Griffin; Paul Corcoran; Linda Cassidy; Amanda O'Carroll; Ivan J Perry; Brendan Bonner
Journal:  BMJ Open       Date:  2014-07-29       Impact factor: 2.692

Review 7.  A Scoping Review of Non-Medical and Extra-Medical Use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs).

Authors:  Rebekah Brennan; Mayyada Wazaify; Haneen Shawabkeh; Ian Boardley; Jim McVeigh; Marie Claire Van Hout
Journal:  Drug Saf       Date:  2021-07-30       Impact factor: 5.606

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.